Introduction: Establishing structural and functional similarity to an approved innovator biologic represents the cornerstone of regulatory approval for biosimilar products […]
Reference Product Selection and Sourcing Strategy for Biosimilar Comparability Studies Read More »
Bioanalytical CRO for Oncology Clinical Trials: Complex Matrices, PD Biomarkers, and Regulatory Expectations Within the highly specialized field of oncology
Introduction: Implementation of Nitrosamine Testing for Injectable Drug Products is a critical safety and regulatory requirement because parenteral drug products
Introduction: The immunogenicity of peptide-oligonucleotide conjugates is one of the most consequential development risks facing sponsors working with this rapidly
Introduction: PLGA Formulation Development Services encompass a highly specialized range of contract research capabilities aimed at transforming complex active pharmaceutical
Advanced Extractables & Leachables Testing for Ophthalmic Drug Products Evaluating extractables and leachables in ophthalmic formulations demands a detailed understanding
Introduction: Biosimilar development is analytically demanding. Regulatory agencies — Health Canada, the FDA, and the EMA alike — require manufacturers
Introduction to Peptide-Oligonucleotide Conjugates Specification Setting Peptide-Oligonucleotide Conjugates Specification Setting is the systematic process of establishing scientifically justified physical, chemical,
Specification Setting and Acceptance Criteria for Peptide-Oligonucleotide Conjugates Read More »
Introduction: Selecting the correct sterilization methods for PLGA drug products is one of the most consequential decisions in pharmaceutical formulation
Introduction: Nitrosamine testing for metformin is no longer optional — it is a regulatory and patient safety requirement that every
